Inoculation of 3 x 10(4) to 3 x 10(5) CC531 colon adenocarcinoma cells into the portal vein of syngeneic WAG/Rij rats provides a reproducible animal model of colon cancer liver metastasis with macroscopically visible tumor nodules at day 25 after inoculation. In this study, the inflammatory cell response immune reactive cells accumulated in the liver sinusoids of tumor-bearing livers, especially resident Kupffer cells (KC; ED1+/ED2+), and to a lesser extent pit cells (OX8+/OX19-), T lymphocytes (OX8+lOX19+) and polymorphonuclear leukocytes (PMN; HIS48+). All these cell types may be involved in the lysis of CC531 cells in the liver, although only major histocompatibility complex class II+ monocytes (3D11+/ED1+/ED2-), but not resident KC, T l...
This experimental study was designed to cause a large dominant visible lesion in the presence of mul...
In this study we used the colon carcinoma DHDK12 cell line and generated single metastasis after sub...
Efficacy of a combination therapy with two biological response modifiers (BRMs), oral PSK and system...
Inoculation of 3 x 10(4) to 3 x 10(5) CC531 colon adenocarcinoma cells into the portal vein of synge...
A reliable model with liver metastases of colon cancer was established in this study by injecting DH...
Liver metastases were produced in syngeneic BD IX rats by intraportal injection of colon cancer cell...
Intraportal inoculation of CC531 adenocarcinoma cells into syngeneic rats causes an increase of live...
Although Kupffer cells (KCs) play an important role in the liver\u27s immune response, their role in...
Hepatic metastases are a frequent cause of mortality in colon cancer patients. Many patients with he...
Contains fulltext : 80074.pdf (publisher's version ) (Closed access)Liver metastas...
International audienceIn this study we used the colon carcinoma DHDK12 cell line and generated singl...
Background: The local and systemic activation and regulation of the immune system by malignant cells...
BACKGROUND: Half of the patients with colorectal cancer develop liver metastases during the course o...
Whether liver metastases from colon cancer are capa-ble of metastasizing to other sites is an import...
Tumour immunity is a balance between immune mediators that promote tumor progression versus medi...
This experimental study was designed to cause a large dominant visible lesion in the presence of mul...
In this study we used the colon carcinoma DHDK12 cell line and generated single metastasis after sub...
Efficacy of a combination therapy with two biological response modifiers (BRMs), oral PSK and system...
Inoculation of 3 x 10(4) to 3 x 10(5) CC531 colon adenocarcinoma cells into the portal vein of synge...
A reliable model with liver metastases of colon cancer was established in this study by injecting DH...
Liver metastases were produced in syngeneic BD IX rats by intraportal injection of colon cancer cell...
Intraportal inoculation of CC531 adenocarcinoma cells into syngeneic rats causes an increase of live...
Although Kupffer cells (KCs) play an important role in the liver\u27s immune response, their role in...
Hepatic metastases are a frequent cause of mortality in colon cancer patients. Many patients with he...
Contains fulltext : 80074.pdf (publisher's version ) (Closed access)Liver metastas...
International audienceIn this study we used the colon carcinoma DHDK12 cell line and generated singl...
Background: The local and systemic activation and regulation of the immune system by malignant cells...
BACKGROUND: Half of the patients with colorectal cancer develop liver metastases during the course o...
Whether liver metastases from colon cancer are capa-ble of metastasizing to other sites is an import...
Tumour immunity is a balance between immune mediators that promote tumor progression versus medi...
This experimental study was designed to cause a large dominant visible lesion in the presence of mul...
In this study we used the colon carcinoma DHDK12 cell line and generated single metastasis after sub...
Efficacy of a combination therapy with two biological response modifiers (BRMs), oral PSK and system...